Skip to main content

Articles

Page 27 of 27

  1. The accuracy of computer-aided diagnosis (CAD) software is best evaluated by comparison to a gold standard which represents the true status of disease. In many settings, however, knowledge of the true status o...

    Authors: Amita K Manatunga, José Nilo G Binongo and Andrew T Taylor
    Citation: EJNMMI Research 2011 1:5
  2. A qualitative assessment of conventional bone scintigraphy with 99mTc methylene diphosphonate is perceived as an insensitive method for monitoring the treatment response of bone metastases, and we postulated that...

    Authors: Gary JR Cook, Chris Parker, Sue Chua, Bernadette Johnson, Anne-Kirsti Aksnes and Val J Lewington
    Citation: EJNMMI Research 2011 1:4
  3. Receptor for advanced glycation endproducts (RAGE) expression contributes to the impaired angiogenic response to limb ischemia in diabetes. The aim of this study was to detect the effect of increased expressio...

    Authors: Yared Tekabe, Xiaoping Shen, Joane Luma, Drew Weisenberger, Shi Fang Yan, Roland Haubner, Ann Marie Schmidt and Lynne Johnson
    Citation: EJNMMI Research 2011 1:3
  4. The objective of this study was to characterize the in vitro and in vivo properties of the F(ab')2 fragment of panitumumab and to investigate its potential for imaging and radioimmunotherapy.

    Authors: Karen J Wong, Kwamena E Baidoo, Tapan K Nayak, Kayhan Garmestani, Martin W Brechbiel and Diane E Milenic
    Citation: EJNMMI Research 2011 1:1

EANM'24 - Future Congress!

EANM'24 banner horizontal

The 37th Annual Congress of the European Association of Nuclear Medicine

October 19 – 23, 2024
Hamburg, Germany

CCH – Congress Center Hamburg
Congressplatz 1
20355 Hamburg, Germany
URL: https://www.cch.de/en/

The EJNMMI Journal Family and EANM Springer Award

New Content Item

Highlights of our featured content and the latest developments from the EJNMMI group of journals can be found on the EJNMMI Journal Family webpage. There you will also find details about the annual EANM Springer Prize.


Do you want to publish your paper open access?

Details of the OpenChoice option in EJNMMI are available in the submission guidelines.

If your institution has a Read and Publish (Springer Compact) agreement, you may publish your article open access at no cost to you. In addition, you can enjoy full access to all Springer subscription journal content.

Please check the agreement details by participating country here.